RAGE anticorps
Aperçu rapide pour RAGE anticorps (ABIN285943)
Antigène
Voir toutes RAGE (AGER) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Specific for Amino acid sequence 385-399 of human receptor for advanced glycated end products.0.1% NaN3
-
Immunogène
- RAGE antibody was raised in goat using a peptide, PKKPPQRLEWKLNTGRTE, as the immunogen.
-
-
-
-
Indications d'application
-
ELISA: >1:260,676, IHC-P: >1:400, WB: >1:3,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Supplied as liquid whole serum without preservative
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- RAGE (AGER) (Advanced Glycosylation End Product-Specific Receptor (AGER))
-
Autre désignation
- RAGE
-
Sujet
- The Receptor for Advanced Glycosylated End Products (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules that binds molecules that have been irreversibly modified by non-enzymatic glycation and oxidation, and are know as advanced glycation end products (AGEs). It is expressed by endothelium, mononuclear phagocytes, neurons and smooth muscle cells. Whereas RAGE is present at high levels during development, especially in the central nervous system, its levels decline during maturity.
-
Pathways
- Carbohydrate Homeostasis, Toll-Like Receptors Cascades, Smooth Muscle Cell Migration, S100 Proteins
Antigène
-